Sign in
4/A

Changes in Ownership

Adaptive Biotechnologies Corp Filed Acc 0001209191-20-002418

Director sold 15,000 shares at an average $29.29 ($439,351)

  • Director acquired 15,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

DOBMEIER ERIC · Director

Table I: Non-derivative

3 lines
Date Transaction Shares Price Value Owned after D/I
2019-12-26 Exercise or conversion : show line 1 in the form +15,000 $6.32 $94,800 15,000 D
2019-12-26 Sale : show line 2 in the form −14,998 $29.29 $439,291 2 D
2019-12-26 Sale : show line 3 in the form −2 $29.91 $60 0 D
Open-market sales · 15,000 sh · avg $29.29 · $439,351

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2019-12-26 Exercise or conversion : show line 4 in the form Stock Option (Right to Buy) −15,000 85,000 D
Loading xslF345X03/doc4a.xml…